Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05526443 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Recruiting
Start date
January 13, 2023
Completion date
December 31, 2027
Enrollment
1,500 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic carcinoma, pancreatic cancer